Age: 1 year
Plants 1 new Olive tree
CO2 absorbed: 150 kg/year
Evo oil included:
The project
A concrete commitment to the local area
BIOVIIIx has always been deeply committed to environmental conservation, embarking on a journey that has led it to achieve carbon neutrality, win the Up2You PlaNet Green Cup, and—very soon—become a B Corp. For this reason, the company has chosen to support OlivaMi in tackling the *Xylella* issue, which is severely damaging Mediterranean flora and the local businesses that rely on it.
Storytelling
The story of the project
BIOVIIIx is a pharmaceutical company operating in the fields of coagulopathies and rare diseases, specializing in particular in the hemophilia segment. Drawing on the expertise of our management team and our entire workforce, we have developed a model that combines scientific research with a market approach rooted in ethical principles and respect.
Respect for patient health and for the agreements made with partners and suppliers, without ever overlooking the health and well-being of our employees. Respect for our competitors and industry experts who demonstrate their value through their actions, encouraging us to pursue the path we have chosen to take. But, above all, respect for science and research.
With the aim of optimizing existing treatments and working on the development of cutting-edge solutions for hemophilia and rare diseases.
BIOVIIIx has always been deeply committed to environmental protection, embarking on a journey that has led it to achieve carbon neutrality, win the Up2You PlaNet Green Cup, and—very soon—become a B Corp.
For this reason, the company has chosen to support OlivaMi in order to tackle the Xylella problem, which is severely damaging Mediterranean flora and the local businesses that rely on it.
